C-Peptide: A New Mediator of Atherosclerosis in Diabetes

Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasic, Dusica, Walcher, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321614/
https://www.ncbi.nlm.nih.gov/pubmed/22547909
http://dx.doi.org/10.1155/2012/858692
_version_ 1782228965505630208
author Vasic, Dusica
Walcher, Daniel
author_facet Vasic, Dusica
Walcher, Daniel
author_sort Vasic, Dusica
collection PubMed
description Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of effects within different complications of diabetes. In this paper we discuss the role of C-peptide and its effects in the development of atherosclerosis in type 2 diabetic patients.
format Online
Article
Text
id pubmed-3321614
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33216142012-04-30 C-Peptide: A New Mediator of Atherosclerosis in Diabetes Vasic, Dusica Walcher, Daniel Mediators Inflamm Review Article Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of effects within different complications of diabetes. In this paper we discuss the role of C-peptide and its effects in the development of atherosclerosis in type 2 diabetic patients. Hindawi Publishing Corporation 2012 2012-03-22 /pmc/articles/PMC3321614/ /pubmed/22547909 http://dx.doi.org/10.1155/2012/858692 Text en Copyright © 2012 D. Vasic and D. Walcher. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Vasic, Dusica
Walcher, Daniel
C-Peptide: A New Mediator of Atherosclerosis in Diabetes
title C-Peptide: A New Mediator of Atherosclerosis in Diabetes
title_full C-Peptide: A New Mediator of Atherosclerosis in Diabetes
title_fullStr C-Peptide: A New Mediator of Atherosclerosis in Diabetes
title_full_unstemmed C-Peptide: A New Mediator of Atherosclerosis in Diabetes
title_short C-Peptide: A New Mediator of Atherosclerosis in Diabetes
title_sort c-peptide: a new mediator of atherosclerosis in diabetes
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321614/
https://www.ncbi.nlm.nih.gov/pubmed/22547909
http://dx.doi.org/10.1155/2012/858692
work_keys_str_mv AT vasicdusica cpeptideanewmediatorofatherosclerosisindiabetes
AT walcherdaniel cpeptideanewmediatorofatherosclerosisindiabetes

Ejemplares similares